Postoperative Critical Care of the Adult Cardiac Surgical Patient: Part II: Procedure-Specific Considerations, Management of Complications, and Quality Improvement

Critical Care Medicine

Volumn 43, Issue 9, 2015, Pages 1995-2014

  Stephens, R Scott ^a,b   Whitman, Glenn J R ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

aorta; cardiac surgical procedures; coronary artery bypass; intensive care; off pump; postoperative care; quality improvement

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ASCENDING AORTA SURGERY; ASSISTED CIRCULATION; CARDIOPULMONARY BYPASS; CATHETER INFECTION; DECUBITUS; HEART ARREST; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HEART TAMPONADE; HEART VALVE SURGERY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; MEDICAL LITERATURE; MINIMALLY INVASIVE CARDIAC SURGERY; MITRAL VALVE; OFF PUMP SURGERY; PHYSIOTHERAPY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REFRACTORY SHOCK; RESPIRATORY FAILURE; RIGHT VENTRICULAR ASSIST DEVICE; SELF EXAMINATION; SHOCK; SURGICAL INFECTION; SURGICAL PATIENT; TOTAL QUALITY MANAGEMENT; URINARY CATHETER; URINARY CATHETER INFECTION; VASCULAR CATHETER INFECTION; VASOPLEGIA; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; AORTA; CORONARY ARTERY BYPASS GRAFT; HEALTH CARE QUALITY; HEART VALVE; ORGANIZATION AND MANAGEMENT; POSTOPERATIVE COMPLICATIONS; PROCEDURES; STANDARDS; SURGERY;

AORTA; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; CRITICAL CARE; HEART VALVES; HUMANS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; QUALITY ASSURANCE, HEALTH CARE; QUALITY IMPROVEMENT;

EID: 84946118196     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001171     Document Type: Article

References (304)

1. Society of Thoracic Surgeons. Adult Cardiac Surgery Database Executive Summary. Society of Thoracic Surgeons. Available at: http://sts.org/national-database/database-managers/executive-summaries. Access January 24
2. Hillis LD, Smith PK, Anderson JL, et al; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; Society of Cardiovascular Anesthesiologists; Society of Thoracic Surgeons: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Develop in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58:e123-e210
3. Bourassa MG, Fisher LD, Campeau L, et al: Long-term fate of bypass grafts: The Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation 1985; 72:V71-V78
4. Sabik JF III, Lytle BW, Blackstone EH, et al: Comparison of saphenous vein and internal thoracic artery graft patency by coronary system. Ann Thorac Surg 2005; 79:544-551; discussion 544
5. Leavitt BJ, O'Connor GT, Olmstead EM, et al: Use of the internal mammary artery graft and in-hospital mortality and other adverse outcomes associat with coronary artery bypass surgery. Circulation 2001; 103:507-512
6. Dabal RJ, Goss JR, Maynard C, et al: The effect of left internal mammary artery utilization on short-term outcomes after coronary revascularization. Ann Thorac Surg 2003; 76:464-470
7. Mangano DT; Multicenter Study of Perioperative Ischemia Research Group: Aspirin and mortality from coronary bypass surgery. N Engl J M 2002; 347:1309-1317
8. Goldman S, Copeland J, Moritz T, et al: Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group. Circulation 1991; 84:520-526
9. Goldman S, Copeland J, Moritz T, et al: Internal mammary artery and saphenous vein graft patency. Effects of aspirin. Circulation 1990; 82:IV237-IV242
10. Sharma GV, Khuri SF, Josa M, et al: The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency. Circulation 1983; 68:II218-II221
11. Kulik A, Le May MR, Voisine P, et al: Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: The clopidogrel after surgery for coronary artery disease (CASCADE) Trial. Circulation 2010; 122:2680-2687
12. Berger JS, Herout PM, Harshaw Q, et al: Bleing-associat outcomes with preoperative clopidogrel use in on-and off-pump coronary artery bypass. J Thromb Thrombolysis 2012; 34:56-64
13. Berger JS, Frye CB, Harshaw Q, et al: Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: A multicenter analysis. J Am Coll Cardiol 2008; 52:1693-1701
14. Held C, Asenblad N, Bassand JP, et al: Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: Results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 2011; 57:672-684
15. Hansson EC, Rexius H, Dellborg M, et al: Coronary artery bypass grafting-relat bleing complications in real-life acute coronary syndrome patients treat with clopidogrel or ticagrelor. Eur J Cardiothorac Surg 2014; 46:699-705
16. Wiviott SD, Braunwald E, McCabe CH, et al; TRITON-TIMI 38 Investigators: Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J M 2007; 357:2001-2015
17. Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J M 1997; 336:153-162
18. Takagi H, Kawai N, Umemoto T: Preoperative statin therapy ruces postoperative all-cause mortality in cardiac surgery: A metaanalysis of controll studies. J Thorac Cardiovasc Surg 2009; 137:e52-e53
19. Patti G, Chello M, Candura D, et al: Randomiz trial of atorvastatin for ruction of postoperative atrial fibrillation in patients undergoing cardiac surgery: Results of the ARMYDA-3 (Atorvastatin for Ruction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006; 114:1455-1461
20. Layton JB, Kshirsagar AV, Simpson RJ Jr, et al: Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol 2013; 111:823-828
21. Girerd N, Pibarot P, Daleau P, et al: Statins ruce short-and longterm mortality associat with postoperative atrial fibrillation after coronary artery bypass grafting: Impact of postoperative atrial fibrillation and statin therapy on survival. Clin Cardiol 2012; 35:430-436
22. Chello M, Patti G, Candura D, et al: Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care M 2006; 34:660-667
23. Chello M, Goffro C, Patti G, et al: Effects of atorvastatin on arterial endothelial function in coronary bypass surgery. Eur J Cardiothorac Surg 2005; 28:805-810
24. Pullan M, Chalmers J, Miratta N, et al: Statins and long-term survival after isolat valve surgery: The importance of valve type, position and procure. Eur J Cardiothorac Surg 2014; 45:419-424
25. Ferguson TB Jr, Coombs LP, Peterson ; Society of Thoracic Surgeons National Adult Cardiac Surgery Database: Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002; 287:2221-2227
26. ten Broecke PW, De Hert SG, Mertens E, et al: Effect of preoperative beta-blockade on perioperative mortality in coronary surgery. Br J Anaesth 2003; 90:27-31
27. Brinkman W, Herbert MA, O'Brien S, et al: Preoperative ?-blocker use in coronary artery bypass grafting surgery: National database analysis. JAMA Intern M 2014; 174:1320-1327
28. Connolly SJ, Cybulsky I, Lamy A, et al; Beta-Blocker Length Of Stay (BLOS) study: Double-blind, placebo-controll, randomiz trial of prophylactic metoprolol for ruction of hospital length of stay after heart surgery: The beta-Blocker Length Of Stay (BLOS) study. Am Heart J 2003; 145:226-232
29. Andrews TC, Reimold SC, Berlin JA, et al: Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomiz control trials. Circulation 1991; 84:III236-III244
30. Yacoub R, Patel N, Lohr JW, et al: Acute kidney injury and death associat with renin angiotensin system blockade in cardiothoracic surgery: A meta-analysis of observational studies. Am J Kidney Dis 2013; 62:1077-1086
31. Dag O, Kaygin MA, Aydin A, et al: Is administration of preoperative angiotensin-converting enzyme inhibitors important for renal protection after cardiac surgery? Ren Fail 2013; 35:754-760
32. Levin MA, Lin HM, Castillo JG, et al: Early on-cardiopulmonary bypass hypotension and other factors associat with vasoplegic syndrome. Circulation 2009; 120:1664-1671
33. Arora P, Rajagopalam S, Ranjan R, et al: Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associat with increas risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 2008; 3:1266-1273
34. Drenger B, Fontes ML, Miao Y, et al; Investigators of the Ischemia Research and ucation Foundation; Multicenter Study of Perioperative Ischemia Research Group: Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: Effects on inhospital morbidity and mortality. Circulation 2012; 126:261-269
35. Rouleau JL, Warnica WJ, Baillot R, et al; IMAGINE (Ischemia Management with Accupril post-bypass Graft via Inhibition of the coNverting Enzyme) Investigators: Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 2008; 117:24-31
36. Oosterga M, Voors AA, Pinto YM, et al: Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Am J Cardiol 2001; 87:542-546
37. Møller CH, Penninga L, Wetterslev J, et al: Off-pump versus onpump coronary artery bypass grafting for ischaemic heart disease. Cochrane Database Syst Rev 2012; 3:CD007224
38. Kim JB, Yun SC, Lim JW, et al: Long-term survival following coronary artery bypass grafting: Off-pump versus on-pump strategies. J Am Coll Cardiol 2014; 63:2280-2288
39. Shroyer AL, Grover FL, Hattler B, et al; Veterans Affairs Randomiz On/Off Bypass (ROOBY) Study Group: On-pump versus offpump coronary-artery bypass surgery. N Engl J M 2009; 361:1827-1837
40. Lamy A, Devereaux PJ, Prabhakaran D, et al; CORONARY Investigators: Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J M 2012; 366:1489-1497
41. Houlind K, Fenger-Grøn M, Holme SJ, et al; DOORS Study Group: Graft patency after off-pump coronary artery bypass surgery is inferior even with identical heparinization protocols: Results from the Danish On-pump Versus Off-pump Randomization Study (DOORS). J Thorac Cardiovasc Surg 2014; 148:1812-1819.e2
42. Bakaeen FG, Shroyer AL, Gammie JS, et al: Trends in use of off-pump coronary artery bypass grafting: Results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. J Thorac Cardiovasc Surg 2014; 148:856-863, 864.e1
43. Mack MJ, Pfister A, Bachand D, et al: Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease. J Thorac Cardiovasc Surg 2004; 127:167-173
44. Garg AX, Devereaux PJ, Yusuf S, et al; CORONARY Investigators: Kidney function after off-pump or on-pump coronary artery bypass graft surgery: A randomiz clinical trial. JAMA 2014; 311:2191-2198
45. Afilalo J, Rasti M, Ohayon SM, et al: Off-pump vs. on-pump coronary artery bypass surgery: An updat meta-analysis and meta-regression of randomiz trials. Eur Heart J 2012; 33:1257-1267
46. Altarabsheh SE, Deo SV, Rababa'h AM, et al. Off-Pump coronary artery bypass ruces early stroke in octogenarians: A meta-analysis of 18,000 patients. Ann Thorac Surg 2015; 99:1568-1575. doi: 10.1016/j.athoracsur.2014.12.057
47. Lamy A, Devereaux PJ, Prabhakaran D, et al; CORONARY Investigators: Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J M 2013; 368:1179-1188
48. Couture P, Denault A, Limoges P, et al: Mechanisms of hemodynamic changes during off-pump coronary artery bypass surgery. Can J Anaesth 2002; 49:835-849
49. Diegeler A, Börgermann J, Kappert U, et al; GOPCABE Study Group: Off-pump versus on-pump coronary-artery bypass grafting in elderly patients. N Engl J M 2013; 368:1189-1198
50. Omer S, Cornwell LD, Rosengart TK, et al: Completeness of coronary revascularization and survival: Impact of age and off-pump surgery. J Thorac Cardiovasc Surg 2014; 148:1307-1315.e1
51. Kulik A, Rubens FD, Wells PS, et al: Early postoperative anticoagulation after mechanical valve replacement: A systematic review. Ann Thorac Surg 2006; 81:770-781
52. Suri RM, Schaff HV, Dearani JA, et al: Determinants of early decline in ejection fraction after surgical correction of mitral regurgitation. J Thorac Cardiovasc Surg 2008; 136:442-447
53. Tulner SA, Steendijk P, Klautz RJ, et al: Acute hemodynamic effects of restrictive mitral annuloplasty in patients with end-stage heart failure: Analysis by pressure-volume relations. J Thorac Cardiovasc Surg 2005; 130:33-40
54. Witkowski TG, Thomas JD, Debonnaire PJ, et al: Global longitudinal strain pricts left ventricular dysfunction after mitral valve repair. Eur Heart J Cardiovasc Imaging 2013; 14:69-76
55. Witkowski TG, Thomas JD, Delgado V, et al: Changes in left ventricular function after mitral valve repair for severe organic mitral regurgitation. Ann Thorac Surg 2012; 93:754-760
56. Shafii AE, Gillinov AM, Mihaljevic T, et al: Changes in left ventricular morphology and function after mitral valve surgery. Am J Cardiol 2012; 110:403-408.e3
57. Acker MA, Jessup M, Bolling SF, et al: Mitral valve repair in heart failure: Five-year follow-up from the mitral valve replacement stratum of the Acorn randomiz trial. J Thorac Cardiovasc Surg 2011; 142:569-74, 574.e1
58. Acker MA, Bolling S, Shemin R, et al; Acorn Trial Principal Investigators and Study Coordinators: Mitral valve surgery in heart failure: Insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg 2006; 132:568-577, 577.e1
59. Fattouch K, Sbraga F, Bianco G, et al: Inhal prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement. J Card Surg 2005; 20:171-176
60. Lee KS, Stewart WJ, Lever HM, et al: Mechanism of outflow tract obstruction causing fail mitral valve repair. Anterior displacement of leaflet coaptation. Circulation 1993; 88:II24-II29
61. Varghese R, Anyanwu AC, Itagaki S, et al: Management of systolic anterior motion after mitral valve repair: An algorithm. J Thorac Cardiovasc Surg 2012; 143:S2-S7
62. Jebara VA, Mihaileanu S, Acar C, et al: Left ventricular outflow tract obstruction after mitral valve repair. Results of the sliding leaflet technique. Circulation 1993; 88:II30-II34
63. Loulmet DF, Yaffee DW, Ursomanno PA, et al: Systolic anterior motion of the mitral valve: A 30-year perspective. J Thorac Cardiovasc Surg 2014; 148:2787-2793
64. Manabe S, Kasegawa H, Fukui T, et al: Influence of left ventricular function on development of systolic anterior motion after mitral valve repair. J Thorac Cardiovasc Surg 2013; 146:291-5.e1
65. Crescenzi G, Landoni G, Zangrillo A, et al: Management and decisionmaking strategy for systolic anterior motion after mitral valve repair. J Thorac Cardiovasc Surg 2009; 137:320-325
66. Treasure RL, Rainer WG, Strevey TE, et al: Intraoperative left ventricular rupture associat with mitral valve replacement. Chest 1974; 66:511-514
67. Karlson KJ, Ashraf MM, Berger RL: Rupture of left ventricle following mitral valve replacement. Ann Thorac Surg 1988; 46:590-597
68. Brown JM, O'Brien SM, Wu C, et al: Isolat aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009; 137:82-90
69. Fukuda T, Hawley RL, wards JE: Lesions of conduction tissue complicating aortic valvular replacement. Chest 1976; 69:605-614
70. Kim MH, Deeb GM, Eagle KA, Bruckman D, Pelosi F, Oral H et al. Complete atrioventricular block after valvular heart surgery and the timing of pacemaker implantation. Am J Cardiol 2001; 87:649-51, A10.
71. Iturra SA, Suri RM, Greason KL, et al: Outcomes of surgical aortic valve replacement in moderate risk patients: Implications for determination of equipoise in the transcatheter era. J Thorac Cardiovasc Surg 2014; 147:127-132
72. Simms AD, Hogarth AJ, Hudson EA, et al: Ongoing requirement for pacing post-transcatheter aortic valve implantation and surgical aortic valve replacement. Interact Cardiovasc Thorac Surg 2013; 17:328-333
73. Matthews IG, Fazal IA, Bates MG, et al: In patients undergoing aortic valve replacement, what factors prict the requirement for permanent pacemaker implantation? Interact Cardiovasc Thorac Surg 2011; 12:475-479
74. Epstein AE, DiMarco JP, Ellenbogen KA, et al; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Heart Rhythm Society: 2012 ACCF/AHA/HRS focus update incorporat into the ACCF/AHA/HRS 2008 guidelines for device-bas therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2013; 61:e6-75
75. Epstein AE, DiMarco JP, Ellenbogen KA, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons: ACC/AHA/HRS 2008 Guidelines for Device-Bas Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) develop in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 51:e1-62
76. Kincaid EH, Cordell AR, Hammon JW, et al: Coronary insufficiency after stentless aortic root replacement: Risk factors and solutions. Ann Thorac Surg 2007; 83:964-968
77. Fernández AL, El-Diasty MM, Martínez A, et al: A simple technique to rule out occlusion of right coronary artery after aortic valve surgery. Ann Thorac Surg 2011; 92:2281-2282
78. Kilic A, Saha-Chaudhuri P, Rankin JS, et al: Trends and outcomes of tricuspid valve surgery in North America: An analysis of more than 50,000 patients from the Society of Thoracic Surgeons database. Ann Thorac Surg 2013; 96:1546-1552
79. Guenther T, Noebauer C, Mazzitelli D, et al: Tricuspid valve surgery: A thirty-year assessment of early and late outcome. Eur J Cardiothorac Surg 2008; 34:402-409
80. Singh SK, Tang GH, Maganti MD, et al: Midterm outcomes of tricuspid valve repair versus replacement for organic tricuspid disease. Ann Thorac Surg 2006; 82:1735-1741
81. Zehr KJ, Orszulak TA, Mullany CJ, et al: Surgery for aneurysms of the aortic root: A 30-year experience. Circulation 2004; 110:1364-1371
82. Blauth CI, Cosgrove DM, Webb BW, et al: Atheroembolism from the ascending aorta. An emerging problem in cardiac surgery. J Thorac Cardiovasc Surg 1992; 103:1104-1111
83. Shirasaka T, Okada K, Kano H, et al: New indicator of postoperative delay awakening after total aortic arch replacement. Eur J Cardiothorac Surg 2015; 47:101-105
84. Mazzeffi M, Marotta M, Lin HM, et al: Duration of deep hypothermia during aortic surgery and the risk of perioperative blood transfusion. Ann Card Anaesth 2012; 15:266-273
85. Williams JB, Phillips-Bute B, Bhattacharya SD, et al: Prictors of massive transfusion with thoracic aortic procures involving deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg 2011; 141:1283-1288
86. Cameron DE, Vricella LA. Valve-sparing aortic root replacement in Marfan syndrome. Semin Thorac Cardiovasc Surg Piatr Card Surg Annu 2005;103-111
87. Ergin MA, Griepp RB: Composite aortic valve replacement and graft replacement of the ascending aorta plus coronary ostial reimplantation: How I do it. Semin Thorac Cardiovasc Surg 1993; 5:88-90
88. Koh TW, Ferdinand FD, Jin XY, et al: Coronary artery problems during homograft aortic valve replacement: Role of transesophageal echocardiography. Ann Thorac Surg 1997; 64:533-535
89. Gajic O, Dabbagh O, Park PK, et al; U.S. Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITGLIPS): Early identification of patients at risk of acute lung injury: Evaluation of lung injury priction score in a multicenter cohort study. Am J Respir Crit Care M 2011; 183:462-470
90. Stephens RS, Shah AS, Whitman GJ: Lung injury and acute respiratory distress syndrome after cardiac surgery. Ann Thorac Surg 2013; 95:1122-1129
91. Grossi EA, Loulmet DF, Schwartz CF, et al: Evolution of operative techniques and perfusion strategies for minimally invasive mitral valve repair. J Thorac Cardiovasc Surg 2012; 143:S68-S70
92. Mandal K, Alwair H, Nifong WL, et al: Robotically assist minimally invasive mitral valve surgery. J Thorac Dis 2013; 5 Suppl 6:S694-S703
93. Adams DH, Popma JJ, Reardon MJ, et al; U.S. CoreValve Clinical Investigators: Transcatheter aortic-valve replacement with a selfexpanding prosthesis. N Engl J M 2014; 370:1790-1798
94. Makkar RR, Fontana GP, Jilaihawi H, et al; PARTNER Trial Investigators: Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J M 2012; 366:1696-1704
95. Leon MB, Smith CR, Mack M, et al; PARTNER Trial Investigators: Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J M 2010; 363:1597-1607
96. Smith CR, Leon MB, Mack MJ, et al; PARTNER Trial Investigators: Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J M 2011; 364:2187-2198
97. Tomey MI, Gidwani UK, Sharma SK: Cardiac critical care after transcatheter aortic valve replacement. Cardiol Clin 2013; 31:607-618, ix.
98. Athappan G, Gajulapalli RD, Sengodan P, et al: Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: A meta-analysis and systematic review of literature. J Am Coll Cardiol 2014; 63:2101-2110
99. Eggebrecht H, Schmermund A, Voigtländer T, et al: Risk of stroke after transcatheter aortic valve implantation (TAVI): A meta-analysis of 10,037 publish patients. EuroIntervention 2012; 8:129-138
100. Miller DC, Blackstone EH, Mack MJ, et al; PARTNER Trial Investigators and Patients; PARTNER Stroke Substudy Writing Group and Executive Committee: Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: Occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg 2012; 143:832-843.e13
101. Généreux P, Kodali SK, Green P, et al: Incidence and effect of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria. Am J Cardiol 2013; 111:100-105
102. Barbanti M, Yang TH, Rodès Cabau J, et al: Anatomical and procural features associat with aortic root rupture during balloonexpandable transcatheter aortic valve replacement. Circulation 2013; 128:244-253
103. Ribeiro HB, Webb JG, Makkar RR, et al: Prictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: Insights from a large multicenter registry. J Am Coll Cardiol 2013; 62:1552-1562
104. Guru V, Tu JV, Etchells E, et al: Relationship between preventability of death after coronary artery bypass graft surgery and all-cause riskadjust mortality rates. Circulation 2008; 117:2969-2976
105. Ahm EO, Butler R, Novick RJ: Failure-to-rescue rate as a measure of quality of care in a cardiac surgery recovery unit: A five-year study. Ann Thorac Surg 2014; 97:147-152
106. Rozental T, Shore-Lesserson L: Pharmacologic management of coagulopathy in cardiac surgery: An update. J Cardiothorac Vasc Anesth 2012; 26:669-679
107. Christensen MC, Krapf S, Kempel A, et al: Costs of excessive postoperative hemorrhage in cardiac surgery. J Thorac Cardiovasc Surg 2009; 138:687-693
108. Whitlock R, Crowther MA, Ng HJ: Bleing in cardiac surgery: Its prevention and treatment-an evidence-bas review. Crit Care Clin 2005; 21:589-610
109. Ranucci M, Baryshnikova E, Castelvecchio S, et al; Surgical and Clinical Outcome Research (SCORE) Group: Major bleing, transfusions, and anemia: The deadly triad of cardiac surgery. Ann Thorac Surg 2013; 96:478-485
110. Fergusson DA, Hébert PC, Mazer CD, et al; BART Investigators: A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J M 2008; 358:2319-2331
111. Herwaldt LA, Swartzendruber SK, Zimmerman MB, et al: Hemorrhage after coronary artery bypass graft procures. Infect Control Hosp Epidemiol 2003; 24:44-50
112. Dyke C, Aronson S, Dietrich W, et al: Universal definition of perioperative bleing in adult cardiac surgery. J Thorac Cardiovasc Surg 2014; 147:1458-1463.e1
113. Dixon B, Santamaria JD, Reid D, et al: The association of blood transfusion with mortality after cardiac surgery: Cause or confounding? (CME). Transfusion 2013; 53:19-27
114. Christensen MC, Dziewior F, Kempel A, et al: Increas chest tube drainage is independently associat with adverse outcome after cardiac surgery. J Cardiothorac Vasc Anesth 2012; 26:46-51
115. Ferraris VA, Ferraris SP, Saha SP, Hessel EA, Haan CK, Royston BD et al. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83:S27-S86
116. Ferraris VA, Davenport DL, Saha SP, et al: Intraoperative transfusion of small amounts of blood heralds worse postoperative outcome in patients having noncardiac thoracic operations. Ann Thorac Surg 2011; 91:1674-1680
117. Dixon B, Reid D, Collins M, et al: The operating surgeon is an independent prictor of chest tube drainage following cardiac surgery. J Cardiothorac Vasc Anesth 2014; 28:242-246
118. Becker RC, Bassand JP, Budaj A, et al: Bleing complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J 2011; 32:2933-2944
119. Brown C, Joshi B, Faraday N, et al: Emergency cardiac surgery in patients with acute coronary syndromes: A review of the evidence and perioperative implications of mical and mechanical therapeutics. Anesth Analg 2011; 112:777-799
120. Vuylsteke A, Pagel C, Gerrard C, et al: The Papworth Bleing Risk Score: A stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleing. Eur J Cardiothorac Surg 2011; 39:924-930
121. Greiff G, Pleym H, Stenseth R, et al: Priction of bleing after cardiac surgery: Comparison of model performances: A prospective observational study. J Cardiothorac Vasc Anesth 2015; 29:311-319
122. Kutcher ME, Kornblith LZ, Narayan R, et al: A paradigm shift in trauma resuscitation: Evaluation of evolving massive transfusion practices. JAMA Surg 2013; 148:834-840
123. Reynolds BR, Forsythe RM, Harbrecht BG, et al; Inflammation and Host Response to Injury Investigators: Hypothermia in massive transfusion: Have we been paying enough attention to it? J Trauma Acute Care Surg 2012; 73:486-491
124. Morrison CA, Carrick MM, Norman MA, et al: Hypotensive resuscitation strategy ruces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock: Preliminary results of a randomiz controll trial. J Trauma 2011; 70:652-663
125. Dutton RP, Mackenzie CF, Scalea TM: Hypotensive resuscitation during active hemorrhage: Impact on in-hospital mortality. J Trauma 2002; 52:1141-1146
126. Sivarajan M, Amory DW, Everett GB, et al: Blood pressure, not cardiac output, determines blood loss during induc hypotension. Anesth Analg 1980; 59:203-206
127. Ilabaca PA, Ochsner JL, Mills NL: Positive end-expiratory pressure in the management of the patient with a postoperative bleing heart. Ann Thorac Surg 1980; 30:281-284
128. Hoffman WS, Tomasello DN, MacVaugh H: Control of postcardiotomy bleing with PEEP. Ann Thorac Surg 1982; 34:71-73
129. Zink KA, Sambasivan CN, Holcomb JB, et al: A high ratio of plasma and platelets to pack r blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg 2009; 197:565-570
130. Perkins JG, Cap AP, Weiss BM, et al: Massive transfusion and nonsurgical hemostatic agents. Crit Care M 2008; 36:S325-S339
131. Davidson S: State of the art-how I manage coagulopathy in cardiac surgery patients. Br J Haematol 2014; 164:779-789
132. Reikvam H, Steien E, Hauge B, et al: Thrombelastography. Transfus Apher Sci 2009; 40:119-123
133. Arnékian V, Camous J, Fattal S, et al: Use of prothrombin complex concentrate for excessive bleing after cardiac surgery. Interact Cardiovasc Thorac Surg 2012; 15:382-389
134. Bowman LJ, Uber WE, Stroud MR, et al: Use of recombinant activat factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery. Ann Thorac Surg 2008; 85:1669-1676
135. Levi M, Levy JH, Andersen HF, et al: Safety of recombinant activat factor VII in randomiz clinical trials. N Engl J M 2010; 363:1791-1800
136. Uber WE, Toole JM, Stroud MR, et al: Administration of recombinant activat factor VII in the intensive care unit after complex cardiovascular surgery: Clinical and economic outcomes. J Thorac Cardiovasc Surg 2011; 141:1469-77.e2
137. Gill R, Herbertson M, Vuylsteke A, et al: Safety and efficacy of recombinant activat factor VII: A randomiz placebo-controll trial in the setting of bleing after cardiac surgery. Circulation 2009; 120:21-27
138. Besser MW, Ortmann E, Klein AA: Haemostatic management of cardiac surgical haemorrhage. Anaesthesia 2015; 70 Suppl 1: 87-95, e29
139. Besser MW, Klein AA: The coagulopathy of cardiopulmonary bypass. Crit Rev Clin Lab Sci 2010; 47:197-212
140. Vivacqua A, Koch CG, Yousuf AM, et al: Morbidity of bleing after cardiac surgery: Is it blood transfusion, reoperation for bleing, or both? Ann Thorac Surg 2011; 91:1780-1790
141. Karthik S, Grayson AD, McCarron EE, et al: Reexploration for bleing after coronary artery bypass surgery: Risk factors, outcomes, and the effect of time delay. Ann Thorac Surg 2004; 78:527-534
142. Fairman RM, munds LH Jr: Emergency thoracotomy in the surgical intensive care unit after open cardiac operation. Ann Thorac Surg 1981; 32:386-391
143. Fischer GW, Levin MA: Vasoplegia during cardiac surgery: Current concepts and management. Semin Thorac Cardiovasc Surg 2010; 22:140-144
144. Gomes WJ, Carvalho AC, Palma JH, et al: Vasoplegic syndrome after open heart surgery. J Cardiovasc Surg (Torino) 1998; 39:619-623
145. Papadopoulos G, Sintou E, Siminelakis S, et al: Perioperative infusion of low-dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomiz study. J Cardiothorac Surg 2010; 5:17
146. Morales DL, Garrido MJ, Madigan JD, et al: A double-blind randomiz trial: Prophylactic vasopressin ruces hypotension after cardiopulmonary bypass. Ann Thorac Surg 2003; 75:926-930
147. Lenglet S, Mach F, Montecucco F: Methylene blue: Potential use of an antique molecule in vasoplegic syndrome during cardiac surgery. Expert Rev Cardiovasc Ther 2011; 9:1519-1525
148. Levin RL, Degrange MA, Bruno GF, et al: Methylene blue ruces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 2004; 77:496-499
149. Carmona P, Mateo E, Casanovas I, et al: Management of cardiac tamponade after cardiac surgery. J Cardiothorac Vasc Anesth 2012; 26:302-311
150. Kuvin JT, Harati NA, Pandian NG, et al: Postoperative cardiac tamponade in the modern surgical era. Ann Thorac Surg 2002; 74:1148-1153
151. Price S, Prout J, Jaggar SI, et al: 'Tamponade' following cardiac surgery: Terminology and echocardiography may both mislead. Eur J Cardiothorac Surg 2004; 26:1156-1160
152. Mebazaa A, Pitsis AA, Rudiger A, et al: Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care 2010; 14:201
153. Gillies M, Bellomo R, Doolan L, et al: Bench-to-bside review: Inotropic drug therapy after adult cardiac surgery-a systematic literature review. Crit Care 2005; 9:266-279
154. Levy B, Perez P, Perny J, et al: Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomiz pilot study. Crit Care M 2011; 39:450-455
155. Itagaki S, Hosseinian L, Varghese R: Right ventricular failure after cardiac surgery: Management strategies. Semin Thorac Cardiovasc Surg 2012; 24:188-194
156. Price LC, Wort SJ, Finney SJ, et al: Pulmonary vascular and right ventricular dysfunction in adult critical care: Current and emerging options for management: A systematic literature review. Crit Care 2010; 14:R169
157. Winterhalter M, Simon A, Fischer S, et al: Comparison of inhal iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: A prospective randomiz trial. J Cardiothorac Vasc Anesth 2008; 22:406-413
158. Antoniou T, Koletsis EN, Prokakis C, et al: Hemodynamic effects of combination therapy with inhal nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery. J Cardiothorac Vasc Anesth 2013; 27:459-466
159. Fullerton DA, McIntyre RC Jr, Kirson LE, et al: Impact of respiratory acid-base status in patients with pulmonary hypertension. Ann Thorac Surg 1996; 61:696-701
160. Fullerton DA, Kirson LE, St Cyr JA, et al: The influence of respiratory acid-base status on adult pulmonary vascular resistance before and after cardiopulmonary bypass. Chest 1993; 103:1091-1095
161. Lahm T, McCaslin CA, Wozniak TC, et al: Mical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol 2010; 56:1435-1446
162. Dünser MW, Mayr AJ, Ulmer H, et al: The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: A retrospective analysis. Anesth Analg 2001; 93:7-13
163. Braun EB, Palin CA, Hogue CW: Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treat with intravenous epoprostenol. Anesth Analg 2004; 99:36-37
164. Currigan DA, Hughes RJ, Wright CE, et al: Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: An in vitro study. Anesthesiology 2014; 121:930-936
165. Lazar JF, Swartz MF, Schiralli MP, et al: Survival after left ventricular assist device with and without temporary right ventricular support. Ann Thorac Surg 2013; 96:2155-2159
166. Cheung AW, White CW, Davis MK, et al: Short-term mechanical circulatory support for recovery from acute right ventricular failure: Clinical outcomes. J Heart Lung Transplant 2014; 33:794-799
167. Kapur NK, Paruchuri V, Jagannathan A, et al: Mechanical circulatory support for right ventricular failure. JACC Heart Fail 2013; 1:127-134
168. Werdan K, Gielen S, Ebelt H, et al: Mechanical circulatory support in cardiogenic shock. Eur Heart J 2014; 35:156-167
169. Samuels LE, Kaufman MS, Thomas MP, et al: Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: Experience with the Abiom BVS system. J Card Surg 1999; 14:288-293
170. Baskett RJ, Ghali WA, Maitland A, et al: The intraaortic balloon pump in cardiac surgery. Ann Thorac Surg 2002; 74:1276-1287
171. Thiele H, Zeymer U, Neumann FJ, et al; IABP-SHOCK II Trial Investigators: Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J M 2012; 367:1287-1296
172. Lombard FW, Grichnik KP: Update on management strategies for separation from cardiopulmonary bypass. Curr Opin Anaesthesiol 2011; 24:49-57
173. Rastan AJ, Tillmann E, Subramanian S, et al: Visceral arterial compromise during intra-aortic balloon counterpulsation therapy. Circulation 2010; 122:S92-S99
174. Sylvin EA, Stern DR, Goldstein DJ: Mechanical support for postcardiotomy cardiogenic shock: Has progress been made? J Card Surg 2010; 25:442-454
175. Guyton RA, Schonberger JP, Everts PA, et al: Postcardiotomy shock: Clinical evaluation of the BVS 5000 Biventricular Support System. Ann Thorac Surg 1993; 56:346-356
176. Körfer R, El-Banayosy A, Arusoglu L, et al: Temporary pulsatile ventricular assist devices and biventricular assist devices. Ann Thorac Surg 1999; 68:678-683
177. Jurmann MJ, Siniawski H, Erb M, et al: Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg 2004; 77:1642-1647
178. Siegenthaler MP, Brehm K, Strecker T, et al: The Impella Recover microaxial left ventricular assist device ruces mortality for postcardiotomy failure: A three-center experience. J Thorac Cardiovasc Surg 2004; 127:812-822
179. Engström AE, Granfeldt H, Seybold-Epting W, et al: Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: A three-center experience. Minerva Cardioangiol 2013; 61:539-546
180. Lemaire A, Anderson MB, Lee LY, et al: The Impella device for acute mechanical circulatory support in patients in cardiogenic shock. Ann Thorac Surg 2014; 97:133-138
181. Griffith BP, Anderson MB, Samuels LE, et al: The RECOVER I: A multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg 2013; 145:548-554
182. Neragi-Miandoab S, Goldstein D, D'Alessandro DA: TandemHeart device as rescue therapy in the management of acute heart failure. Heart Surg Forum 2014; 17:E160-E162
183. Tempelhof MW, Klein L, Cotts WG, et al: Clinical experience and patient outcomes associat with the TandemHeart percutaneous transseptal assist device among a heterogeneous patient population. ASAIO J 2011; 57:254-261
184. Borisenko O, Wylie G, Payne J, et al: Thoratec CentriMag for temporary treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency: A systematic literature review and meta-analysis of observational studies. ASAIO J 2014; 60:487-497
185. Takayama H, Soni L, Kalesan B, et al: Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail 2014; 7:799-806
186. Mikus E, Tripodi A, Calvi S, et al: CentriMag venoarterial extracorporeal membrane oxygenation support as treatment for patients with refractory postcardiotomy cardiogenic shock. ASAIO J 2013; 59:18-23
187. Takayama H, Truby L, Koekort M, et al: Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant 2013; 32:106-111
188. Flécher E, Anselmi A, Corbineau H, et al: Current aspects of extracorporeal membrane oxygenation in a tertiary referral centre: Determinants of survival at follow-up. Eur J Cardiothorac Surg 2014; 46:665-671
189. Loforte A, Pilato E, Martin Suarez S, et al: RotaFlow and CentriMag extracorporeal membrane oxygenation support systems as treatment strategies for refractory cardiogenic shock. J Card Surg 2015; 30:201-208
190. Brodie D, Bacchetta M: Extracorporeal membrane oxygenation for ARDS in adults. N Engl J M 2011; 365:1905-1914
191. Petroni T, Harrois A, Amour J, et al: Intra-aortic balloon pump effects on macrocirculation and microcirculation in cardiogenic shock patients support by venoarterial extracorporeal membrane oxygenation. Crit Care M 2014; 42:2075-2082
192. Ma P, Zhang Z, Song T, et al: Combining ECMO with IABP for the treatment of critically Ill adult heart failure patients. Heart Lung Circ 2014; 23:363-368
193. Yang F, Jia ZS, Xing JL, et al: Effects of intra-aortic balloon pump on cerebral blood flow during peripheral venoarterial extracorporeal membrane oxygenation support. J Transl M 2014; 12:106
194. Ventetuolo CE, Muratore CS: Extracorporeal life support in critically ill adults. Am J Respir Crit Care M 2014; 190:497-508
195. Rastan AJ, Lachmann N, Walther T, et al: Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO). Int J Artif Organs 2006; 29:1121-1131
196. Agerstrand CL, Burkart KM, Abrams DC, et al: Blood conservation in extracorporeal membrane oxygenation for acute respiratory distress syndrome. Ann Thorac Surg 2015; 99:590-595
197. Stephens RS: Invit commentary. Ann Thorac Surg 2015; 99:595-596
198. Aissaoui N, Luyt CE, Leprince P, et al: Prictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. Intensive Care M 2011; 37:1738-1745
199. Boehmer JP, Popjes E: Cardiac failure: Mechanical support strategies. Crit Care M 2006; 34:S268-S277
200. Ranucci M, Ballotta A, Castelvecchio S, et al; Surgical and Clinical Outcome REsearch (SCORE) Group: Perioperative heart failure in coronary surgery and timing of intra-aortic balloon pump insertion. Acta Anaesthesiol Scand 2010; 54:878-884
201. Böning A, Buschbeck S, Roth P, et al: IABP before cardiac surgery: Clinical benefit compar to intraoperative implantation. Perfusion 2013; 28:103-108
202. Ranucci M, Castelvecchio S, Biondi A, et al; Surgical and Clinical Outcome Research (SCORE) Group: A randomiz controll trial of preoperative intra-aortic balloon pump in coronary patients with poor left ventricular function undergoing coronary artery bypass surgery. Crit Care M 2013; 41:2476-2483
203. Kucuker A, Cetin L, Kucuker SA, et al: Single-centre experience with perioperative use of intraaortic balloon pump in cardiac surgery. Heart Lung Circ 2014; 23:475-481
204. Boeken U, Feindt P, Litmathe J, et al: Intraaortic balloon pumping in patients with right ventricular insufficiency after cardiac surgery: Parameters to prict failure of IABP Support. Thorac Cardiovasc Surg 2009; 57:324-328
205. Rastan AJ, Dege A, Mohr M, et al: Early and late outcomes of 517 consecutive adult patients treat with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010; 139:302-311, 311.e1
206. Bartlett RH, Roloff DW, Custer JR, et al: Extracorporeal life support: The University of Michigan experience. JAMA 2000; 283:904-908
207. Smira NG, Moazami N, Golding CM, et al: Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: Survival at five years. J Thorac Cardiovasc Surg 2001; 122:92-102
208. Slaughter MS, Pagani FD, Rogers JG, et al; HeartMate II Clinical Investigators: Clinical management of continuous-flow left ventricular assist devices in advanc heart failure. J Heart Lung Transplant 2010; 29:S1-39
209. Pratt AK, Shah NS, Boyce SW: Left ventricular assist device management in the ICU. Crit Care M 2014; 42:158-168
210. Dunning J, Fabbri A, Kolh PH, et al; EACTS Clinical Guidelines Committee: Guideline for resuscitation in cardiac arrest after cardiac surgery. Eur J Cardiothorac Surg 2009; 36:3-28
211. Herrmann C: Cardiac advanc life support-surgical guideline: Overview and implementation. AACN Adv Crit Care 2014; 25:123-129
212. Mackay JH, Powell SJ, Osgathorp J, et al: Six-year prospective audit of chest reopening after cardiac arrest. Eur J Cardiothorac Surg 2002; 22:421-425
213. McKowen RL, Magovern GJ, Liebler GA, et al: Infectious complications and cost-effectiveness of open resuscitation in the surgical intensive care unit after cardiac surgery. Ann Thorac Surg 1985; 40:388-392
214. Rousou JA, Engelman RM, Flack JE III, et al: Emergency cardiopulmonary bypass in the cardiac surgical unit can be a lifesaving measure in postoperative cardiac arrest. Circulation 1994; 90:II280-II284
215. Selnes OA, Gottesman RF: Neuropsychological outcomes after coronary artery bypass grafting. J Int Neuropsychol Soc 2010; 16:221-226
216. Hocker S, Wijdicks EF, Biller J: Neurologic complications of cardiac surgery and interventional cardiology. Handb Clin Neurol 2014; 119:193-208
217. Selim M: Perioperative stroke. N Engl J M 2007; 356:706-713
218. Tarakji KG, Sabik JF III, Bhudia SK, et al: Temporal onset, risk factors, and outcomes associat with stroke after coronary artery bypass grafting. JAMA 2011; 305:381-390
219. Stamou SC: Stroke and encephalopathy after cardiac surgery: The search for the holy grail. Stroke 2006; 37:284-285
220. Floyd TF, Shah PN, Price CC, et al: Clinically silent cerebral ischemic events after cardiac surgery: Their incidence, regional vascular occurrence, and procural dependence. Ann Thorac Surg 2006; 81:2160-2166
221. McKhann GM, Grega MA, Borowicz LM Jr, et al: Stroke and encephalopathy after cardiac surgery: An update. Stroke 2006; 37:562-571
222. Beaty CA, Arnaoutakis GJ, Grega MA, et al: The role of head comput tomography imaging in the evaluation of postoperative neurologic deficits in cardiac surgery patients. Ann Thorac Surg 2013; 95:548-554
223. Canver CC, Chanda J: Intraoperative and postoperative risk factors for respiratory failure after coronary bypass. Ann Thorac Surg 2003; 75:853-857
224. Hosseinian L, Chiang Y, Itagaki S, et al: Earlier versus later tracheostomy in patients with respiratory failure after cardiac surgery in the Unit States. J Cardiothorac Vasc Anesth 2014; 28:488-492
225. Iribarne A, Burgener JD, Hong K, et al: Quantifying the incremental cost of complications associat with mitral valve surgery in the Unit States. J Thorac Cardiovasc Surg 2012; 143:864-872
226. Horvath KA, Acker MA, Chang H, et al: Blood transfusion and infection after cardiac surgery. Ann Thorac Surg 2013; 95:2194-2201
227. Weissman C: Pulmonary complications after cardiac surgery. Semin Cardiothorac Vasc Anesth 2004; 8:185-211
228. Rubenfeld GD, Caldwell E, Peabody E, et al: Incidence and outcomes of acute lung injury. N Engl J M 2005; 353:1685-1693
229. Tuttle KR, Worrall NK, Dahlstrom LR, et al: Prictors of ARF after cardiac surgical procures. Am J Kidney Dis 2003; 41:76-83
230. Shroyer AL, Coombs LP, Peterson, et al; Society of Thoracic Surgeons: The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003; 75:1856-64; discussion 1864
231. Huen SC, Parikh CR: Pricting acute kidney injury after cardiac surgery: A systematic review. Ann Thorac Surg 2012; 93:337-347
232. Chertow GM, Levy EM, Hammermeister KE, et al: Independent association between acute renal failure and mortality following cardiac surgery. Am J M 1998; 104:343-348
233. Kuitunen A, Vento A, Suojaranta-Ylinen R, et al: Acute renal failure after cardiac surgery: Evaluation of the RIFLE classification. Ann Thorac Surg 2006; 81:542-546
234. Hansen MK, Gammelager H, Jacobsen CJ, et al: Acute kidney injury and long-term risk of cardiovascular events after cardiac surgery: A population-bas cohort study. J Cardiothorac Vasc Anesth 2015; 29:617-625
235. Hansen MK, Gammelager H, Mikkelsen MM, et al: Post-operative acute kidney injury and five-year risk of death, myocardial infarction, and stroke among elective cardiac surgical patients: A cohort study. Crit Care 2013; 17:R292
236. Parolari A, Pesce LL, Pacini D, et al; Monzino Research Group on Cardiac Surgery Outcomes: Risk factors for perioperative acute kidney injury after adult cardiac surgery: Role of perioperative management. Ann Thorac Surg 2012; 93:584-591
237. Baloria KA, Pillai BS, Goel S, et al: Acute renal dysfunction: Time from coronary angiography to cardiac surgery. Asian Cardiovasc Thorac Ann 2013; 21:649-654
238. Shahin J, DeVarennes B, Tse CW, et al: The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery. Crit Care 2011; 15:R162
239. Hillis LD, Smith PK, Anderson JL, et al: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124:2610-2642
240. Gummert JF, Barten MJ, Hans C, et al: Miastinitis and cardiac surgery-an updat risk factor analysis in 10,373 consecutive adult patients. Thorac Cardiovasc Surg 2002; 50:87-91
241. Fowler VG Jr, Kaye KS, Simel DL, et al: Staphylococcus aureus bacteremia after mian sternotomy: Clinical utility of blood culture results in the identification of postoperative miastinitis. Circulation 2003; 108:73-78
242. Brady JD, Rich TC, Le X, et al: Functional role of lipid raft microdomains in cyclic nucleotide-gat channel activation. Mol Pharmacol 2004; 65:503-511
243. Ridderstolpe L, Gill H, Granfeldt H, et al: Superficial and deep sternal wound complications: Incidence, risk factors and mortality. Eur J Cardiothorac Surg 2001; 20:1168-1175
244. Risnes I, Abdelnoor M, Almdahl SM, et al: Miastinitis after coronary artery bypass grafting risk factors and long-term survival. Ann Thorac Surg 2010; 89:1502-1509
245. Miller LG, McKinnell JA, Vollmer ME, et al: Impact of methicillin-resistant Staphylococcus aureus prevalence among S. aureus isolates on surgical site infection risk after coronary artery bypass surgery. Infect Control Hosp Epidemiol 2011; 32:342-350
246. Lador A, Nasir H, Mansur N, et al: Antibiotic prophylaxis in cardiac surgery: Systematic review and meta-analysis. J Antimicrob Chemother 2012; 67:541-550
247. Mertz D, Johnstone J, Loeb M: Does duration of perioperative antibiotic prophylaxis matter in cardiac surgery? A systematic review and meta-analysis. Ann Surg 2011; 254:48-54
248. Walsh EE, Greene L, Kirshner R: Sustain ruction in methicillinresistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern M 2011; 171:68-73
249. Tom TS, Kruse MW, Reichman RT: Update: Methicillin-resistant Staphylococcus aureus screening and decolonization in cardiac surgery. Ann Thorac Surg 2009; 88:695-702
250. van Rijen MM, Bode LG, Baak DA, et al: Ruc costs for Staphylococcus aureus carriers treat prophylactically with mupirocin and chlorhexidine in cardiothoracic and orthopaic surgery. PLoS One 2012; 7:e43065
251. Schweizer M, Perencevich E, McDanel J, et al: Effectiveness of a bundl intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopic surgery: Systematic review and meta-analysis. BMJ 2013; 346:f2743
252. Pronovost P, Neham D, Berenholtz S, et al: An intervention to decrease catheter-relat bloodstream infections in the ICU. N Engl J M 2006; 355:2725-2732
253. Pronovost PJ, Goeschel CA, Colantuoni E, et al: Sustaining ructions in catheter relat bloodstream infections in Michigan intensive care units: Observational study. BMJ 2010; 340:c309
254. O'Horo JC, Maki DG, Krupp AE, et al: Arterial catheters as a source of bloodstream infection: A systematic review and meta-analysis. Crit Care M 2014; 42:1334-1339
255. Gowardman JR, Lipman J, Rickard CM: Assessment of peripheral arterial catheters as a source of sepsis in the critically ill: A narrative review. J Hosp Infect 2010; 75:12-18
256. Koh DB, Gowardman JR, Rickard CM, et al: Prospective study of peripheral arterial catheter infection and comparison with concurrently sit central venous catheters. Crit Care M 2008; 36:397-402
257. Wald HL, Ma A, Bratzler DW, et al: Indwelling urinary catheter use in the postoperative period: Analysis of the national surgical infection prevention project data. Arch Surg 2008; 143:551-557
258. Goldhaber SZ, Hirsch DR, MacDougall RC, et al: Prevention of venous thrombosis after coronary artery bypass surgery (a randomiz trial comparing two mechanical prophylaxis strategies). Am J Cardiol 1995; 76:993-996
259. Schwann TA, Kistler L, Engoren MC, et al: Incidence and prictors of postoperative deep vein thrombosis in cardiac surgery in the era of aggressive thromboprophylaxis. Ann Thorac Surg 2010; 90:760-766
260. Goldhaber SZ, Schoepf UJ: Pulmonary embolism after coronary artery bypass grafting. Circulation 2004; 109:2712-2715
261. Josa M, Siouffi SY, Silverman AB, et al: Pulmonary embolism after cardiac surgery. J Am Coll Cardiol 1993; 21:990-996
262. Cartier R, Robitaille D: Thrombotic complications in beating heart operations. J Thorac Cardiovasc Surg 2001; 121:920-922
263. Gould MK, Garcia DA, Wren SM, et al; American College of Chest Physicians: Prevention of VTE in nonorthopic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th : American College of Chest Physicians Evidence-Bas Clinical Practice Guidelines. Chest 2012; 141:e227S-e277S
264. Kearon C, Akl EA, Comerota AJ, et al; American College of Chest Physicians: Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th : American College of Chest Physicians Evidence-Bas Clinical Practice Guidelines. Chest 2012; 141:e419S-e494S
265. Feuchtinger J, Halfens RJ, Dassen T: Pressure ulcer risk factors in cardiac surgery: A review of the research literature. Heart Lung 2005; 34:375-385
266. Pokorny ME, Koldjeski D, Swanson M: Skin care intervention for patients having cardiac surgery. Am J Crit Care 2003; 12:535-544
267. Sullivan N, Schoelles KM: Preventing in-facility pressure ulcers as a patient safety strategy: A systematic review. Ann Intern M 2013; 158:410-416
268. Andreasen JJ, Nekrasas V, Dethlefsen C: Endoscopic vs open saphenous vein harvest for coronary artery bypass grafting: A prospective randomiz trial. Eur J Cardiothorac Surg 2008; 34:384-389
269. Athanasiou T, Aziz O, Al-Ruzzeh S, et al: Are wound healing disturbances and length of hospital stay ruc with minimally invasive vein harvest? A meta-analysis. Eur J Cardiothorac Surg 2004; 26:1015-1026
270. Goel K, Pack QR, Lahr B, et al: Cardiac rehabilitation is associat with ruc long-term mortality in patients undergoing combin heart valve and CABG surgery. Eur J Prev Cardiol 2015; 22:159-168
271. Pack QR, Goel K, Lahr BD, et al: Participation in cardiac rehabilitation and survival after coronary artery bypass graft surgery: A community-bas study. Circulation 2013; 128:590-597
272. Neham DM, Korupolu R, Zanni JM, et al: Early physical micine and rehabilitation for patients with acute respiratory failure: A quality improvement project. Arch Phys M Rehabil 2010; 91:536-542
273. Truong AD, Fan E, Brower RG, et al: Bench-to-bside review: Mobilizing patients in the intensive care unit-from pathophysiology to clinical trials. Crit Care 2009; 13:216
274. Petrucci L, Ramella FC, Ricotti S, et al: Early rehabilitative treatment in aortocoronary bypass surgery. G Ital M Lav Ergon 2013; 35:125-128
275. Turner DA, Cheifetz IM, Rehder KJ, et al: Active rehabilitation and physical therapy during extracorporeal membrane oxygenation while awaiting lung transplantation: A practical approach. Crit Care M 2011; 39:2593-2598
276. Freeman R, Maley K: Mobilization of intensive care cardiac surgery patients on mechanical circulatory support. Crit Care Nurs Q 2013; 36:73-88
277. Rahimi RA, Skrzat J, Rdy DR, et al: Physical rehabilitation of patients in the intensive care unit requiring extracorporeal membrane oxygenation: A small case series. Phys Ther 2013; 93:248-255
278. Hodgson CL, Stiller K, Neham DM, et al: Expert consensus and recommendations on safety criteria for active mobilization of mechanically ventilat critically ill adults. Crit Care 2014; 18:658
279. Brocki BC, Andreasen J, Nielsen LR, et al: Short and long-term effects of supervis versus unsupervis exercise training on health-relat quality of life and functional outcomes following lung cancer surgery-a randomiz controll trial. Lung Cancer 2014; 83:102-108
280. Westerdahl E, Möller M: Physiotherapy-supervis mobilization and exercise following cardiac surgery: A national questionnaire survey in Swen. J Cardiothorac Surg 2010; 5:67
281. Brocki BC, Thorup CB, Andreasen JJ: Precautions relat to midline sternotomy in cardiac surgery: A review of mechanical stress factors leading to sternal complications. Eur J Cardiovasc Nurs 2010; 9:77-84
282. Tuyl LJ, Mackney JH, Johnston CL: Management of sternal precautions following mian sternotomy by physical therapists in Australia: A web-bas survey. Phys Ther 2012; 92:83-97
283. Parker R, Adams JL, Ogola G, et al: Current activity guidelines for CABG patients are too restrictive: Comparison of the forces exert on the mian sternotomy during a cough vs. lifting activities combin with valsalva maneuver. Thorac Cardiovasc Surg 2008; 56:190-194
284. Shahian DM, Jacobs JP, wards FH, et al: The society of thoracic surgeons national database. Heart 2013; 99:1494-1501
285. Grover FL, Shahian DM, Clark RE, et al: The STS National Database. Ann Thorac Surg 2014; 97:S48-S54
286. Braun BI, Koss RG, Loeb JM: Integrating performance measure data into the Joint Commission accritation process. Eval Health Prof 1999; 22:283-297
287. Kozower BD, Ailawadi G, Jones DR, et al: Prict risk of mortality models: Surgeons ne to understand limitations of the University HealthSystem Consortium models. J Am Coll Surg 2009; 209:551-556
288. Shahian DM, wards FH, Jacobs JP, et al: Public reporting of cardiac surgery performance: Part 1-history, rationale, consequences. Ann Thorac Surg 2011; 92:S2-11
289. Shahian DM, wards FH, Jacobs JP, et al: Public reporting of cardiac surgery performance: Part 2-implementation. Ann Thorac Surg 2011; 92:S12-S23
290. Biancari F, Kangasniemi OP, Luukkonen J, et al: EuroSCORE pricts immiate and late outcome after coronary artery bypass surgery. Ann Thorac Surg 2006; 82:57-61
291. Geissler HJ, Hölzl P, Marohl S, et al: Risk stratification in heart surgery: Comparison of six score systems. Eur J Cardiothorac Surg 2000; 17:400-406
292. Hansen LS, Hjortdal VE, Andreasen JJ, et al: 30-day mortality after coronary artery bypass grafting and valve surgery has greatly improv over the last decade, but the 1-year mortality remains constant. Ann Card Anaesth 2015; 18:138-142
293. Shahian DM, He X, O'Brien SM, et al: Development of a clinical registry-bas 30-day readmission measure for coronary artery bypass grafting surgery. Circulation 2014; 130:399-409
294. Paone G, Brewer R, Likosky DS, et al; Membership of the Michigan Society of Thoracic and Cardiovascular Surgeons: Transfusion rate as a quality metric: Is blood conservation a learnable skill? Ann Thorac Surg 2013; 96:1279-1286
295. Shahian DM, wards FH, Ferraris VA, et al; Society of Thoracic Surgeons Quality Measurement Task Force: Quality measurement in adult cardiac surgery: Part 1-Conceptual framework and measure selection. Ann Thorac Surg 2007; 83:S3-12
296. Sinuff T, Muscere J, Adhikari NK, et al; KRITICAL Working Group, the Canadian Critical Care Trials Group, and the Canadian Critical Care Society: Knowlge translation interventions for critically ill patients: A systematic review. Crit Care M 2013; 41:2627-2640
297. Shake JG, Pronovost PJ, Whitman GJ: Cardiac surgical ICU care: Eliminating "preventable" complications. J Card Surg 2013; 28:406-413
298. Whitman G, Cowell V, Parris K, et al: Prophylactic antibiotic use: Hardwiring of physician behavior, not ucation, leads to compliance. J Am Coll Surg 2008; 207:88-94
299. Stamou SC, Camp SL, Reames MK, et al: Continuous quality improvement program and major morbidity after cardiac surgery. Am J Cardiol 2008; 102:772-777
300. Stamou SC, Camp SL, Stiegel RM, et al: Quality improvement program decreases mortality after cardiac surgery. J Thorac Cardiovasc Surg 2008; 136:494-499.e8
301. Dale CR, Bryson CL, Fan VS, et al: A greater analgesia, sation, delirium order set quality score is associat with a decreas duration of mechanical ventilation in cardiovascular surgery patients. Crit Care M 2013; 41:2610-2617
302. Fitch ZW, Debesa O, Ohkuma R, et al: A protocol-driven approach to early extubation after heart surgery. J Thorac Cardiovasc Surg 2014; 147:1344-1350
303. Fitch ZW, Whitman GJ: Incidence, risk, and prevention of ventilatorassociat pneumonia in adult cardiac surgical patients: A systematic review. J Card Surg 2014; 29:196-203
304. Kilic A, Whitman GJ: Blood transfusions in cardiac surgery: Indications, risks, and conservation strategies. Ann Thorac Surg 2014; 97:726-734